-
Product Insights
NewQuarterly Sweet Spreads pricing trends in the United Kingdom
Empower your strategies with our Quarterly Sweet Spreads pricing trends in the United Kingdom report and make more profitable business decisions. Consumers’ preferences for stores are most heavily influenced by pricing and promotions, but brands and retailers continue to adjust prices and promotions based on insufficient information from expensive, drawn-out, and incomplete audits of rival techniques. Brands and retailers can benefit from the unique intelligence provided by GlobalData Ecommerce Price Tracker, covering millions of SKUs, to identify, anticipate, and implement...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Niraparib in Recurrent Glioblastoma Multiforme (GBM)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Niraparib in Recurrent Glioblastoma Multiforme (GBM) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Niraparib in Recurrent Glioblastoma Multiforme (GBM) Drug Details: Niraparib...
-
Product Insights
NewNet Present Value Model: Pharming Group NV’s Leniolisib
Empower your strategies with our Net Present Value Model: Pharming Group NV's Leniolisib report and make more profitable business decisions. Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence.
-
Product Insights
Innovations in Aesthetic Injectables – Global Pipeline Summary
GlobalData's Medical Devices sector report, "Innovations in Aesthetic Injectables - Global Pipeline Summary" provides comprehensive information about the Aesthetic Injectables pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. The Aesthetic Injectables report provides key information and data related to: Extensive coverage of the Aesthetic Injectables under development Review details of major pipeline products which include product description, licensing and collaboration details and other developmental activities including pipeline territories,...
-
Product Insights
Hyaluronic Acid Fillers Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Hyaluronic Acid Fillers Pipeline Market Report Overview Hyaluronic Acid (HA) is a glycosaminoglycan disaccharide, which exists naturally in the body. Approximately 50% of the total HA is found in the skin. Injections of HA are used for reducing wrinkles in the face and for soft tissue augmentation. The hyaluronic acid fillers pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the...
-
Product Insights
NewAesthetic Injectables Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Aesthetic Injectables Pipeline Market Report Overview Aesthetic injectables are gel-like substances injected beneath the skin to restore a youthful appearance by increasing the volume of sunken cheeks or temples or reducing lines around the nose and mouth, among other processes. Aesthetic Injectables are grouped into segments based on their molecular composition. The aesthetic injectables pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SA-16001 in Allergic Rhinitis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SA-16001 in Allergic Rhinitis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. SA-16001 in Allergic Rhinitis Drug Details: SA-16001 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – HL-237 in Rheumatoid Arthritis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - HL-237 in Rheumatoid Arthritis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. HL-237 in Rheumatoid Arthritis Drug Details: HL-237 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SA-16001 in Asthma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SA-16001 in Asthma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. SA-16001 in Asthma Drug Details: SA-16001 is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – YYC-405 in Type 2 Diabetes
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - YYC-405 in Type 2 Diabetes report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. YYC-405 in Type 2 Diabetes Drug Details: YYC-405 is under development...